These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17337342)

  • 1. Affinity-based ranking of ligands for DPP-4 from mixtures.
    Adam GC; Meng J; Athanasopoulos J; Zhang X; Chapman KT
    Bioorg Med Chem Lett; 2007 May; 17(9):2404-7. PubMed ID: 17337342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of DPP IV inhibitors by pharmacophore modeling and QSAR analysis followed by in silico screening.
    Al-Masri IM; Mohammad MK; Taha MO
    ChemMedChem; 2008 Nov; 3(11):1763-79. PubMed ID: 18989859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [(S)-gamma-(4-Aryl-1-piperazinyl)-l-prolyl]thiazolidines as a novel series of highly potent and long-lasting DPP-IV inhibitors.
    Yoshida T; Sakashita H; Akahoshi F; Hayashi Y
    Bioorg Med Chem Lett; 2007 May; 17(9):2618-21. PubMed ID: 17317162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of 1,4-diazepan-2-one containing dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes.
    Liang GB; Qian X; Feng D; Biftu T; Eiermann G; He H; Leiting B; Lyons K; Petrov A; Sinha-Roy R; Zhang B; Wu J; Zhang X; Thornberry NA; Weber AE
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1903-7. PubMed ID: 17291750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery, SAR, and X-ray structure of novel biaryl-based dipeptidyl peptidase IV inhibitors.
    Qiao L; Baumann CA; Crysler CS; Ninan NS; Abad MC; Spurlino JC; Desjarlais RL; Kervinen J; Neeper MP; Bayoumy SS; Williams R; Deckman IC; Dasgupta M; Reed RL; Huebert ND; Tomczuk BE; Moriarty KJ
    Bioorg Med Chem Lett; 2006 Jan; 16(1):123-8. PubMed ID: 16236500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (3R)-3-amino-4-(2,4,5-trifluorophenyl)-N-{4-[6-(2-methoxyethoxy)benzothiazol-2-yl]tetrahydropyran-4-yl}butanamide as a potent dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
    Nitta A; Fujii H; Sakami S; Nishimura Y; Ohyama T; Satoh M; Nakaki J; Satoh S; Inada C; Kozono H; Kumagai H; Shimamura M; Fukazawa T; Kawai H
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5435-8. PubMed ID: 18819797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, biological evaluation and structural determination of beta-aminoacyl-containing cyclic hydrazine derivatives as dipeptidyl peptidase IV (DPP-IV) inhibitors.
    Ahn JH; Shin MS; Jun MA; Jung SH; Kang SK; Kim KR; Rhee SD; Kang NS; Kim SY; Sohn SK; Kim SG; Jin MS; Lee JO; Cheon HG; Kim SS
    Bioorg Med Chem Lett; 2007 May; 17(9):2622-8. PubMed ID: 17331715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrrolidine-constrained phenethylamines: The design of potent, selective, and pharmacologically efficacious dipeptidyl peptidase IV (DPP4) inhibitors from a lead-like screening hit.
    Backes BJ; Longenecker K; Hamilton GL; Stewart K; Lai C; Kopecka H; von Geldern TW; Madar DJ; Pei Z; Lubben TH; Zinker BA; Tian Z; Ballaron SJ; Stashko MA; Mika AK; Beno DW; Kempf-Grote AJ; Black-Schaefer C; Sham HL; Trevillyan JM
    Bioorg Med Chem Lett; 2007 Apr; 17(7):2005-12. PubMed ID: 17276063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new screening method based on yeast-expressed human dipeptidyl peptidase IV and discovery of novel inhibitors.
    Hu CX; Huang H; Zhang L; Huang Y; Shen ZF; Cheng KD; Du GH; Zhu P
    Biotechnol Lett; 2009 Jul; 31(7):979-84. PubMed ID: 19267232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of new binding elements in DPP-4 inhibition and their applications in novel DPP-4 inhibitor design.
    Liang GB; Qian X; Biftu T; Singh S; Gao YD; Scapin G; Patel S; Leiting B; Patel R; Wu J; Zhang X; Thornberry NA; Weber AE
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3706-10. PubMed ID: 18524582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based virtual screening for low molecular weight chemical starting points for dipeptidyl peptidase IV inhibitors.
    Ward RA; Perkins TD; Stafford J
    J Med Chem; 2005 Nov; 48(22):6991-6. PubMed ID: 16250657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 1: identification of dipeptide derived leads.
    Van der Veken P; De Meester I; Dubois V; Soroka A; Van Goethem S; Maes MB; Brandt I; Lambeir AM; Chen X; Haemers A; Scharpé S; Augustyns K
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4154-8. PubMed ID: 18556199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico fragment-based discovery of DPP-IV S1 pocket binders.
    Rummey C; Nordhoff S; Thiemann M; Metz G
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1405-9. PubMed ID: 16321524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A three-dimensional pharmacophore model for dipeptidyl peptidase IV inhibitors.
    Lu IL; Tsai KC; Chiang YK; Jiaang WT; Wu SH; Mahindroo N; Chien CH; Lee SJ; Chen X; Chao YS; Wu SY
    Eur J Med Chem; 2008 Aug; 43(8):1603-11. PubMed ID: 18207285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 2: isoindoline containing inhibitors.
    Van Goethem S; Van der Veken P; Dubois V; Soroka A; Lambeir AM; Chen X; Haemers A; Scharpé S; De Meester I; Augustyns K
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4159-62. PubMed ID: 18556198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of an Aurora kinase inhibitor through site-specific dynamic combinatorial chemistry.
    Cancilla MT; He MM; Viswanathan N; Simmons RL; Taylor M; Fung AD; Cao K; Erlanson DA
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3978-81. PubMed ID: 18579375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK.
    Waelchli R; Bollbuck B; Bruns C; Buhl T; Eder J; Feifel R; Hersperger R; Janser P; Revesz L; Zerwes HG; Schlapbach A
    Bioorg Med Chem Lett; 2006 Jan; 16(1):108-12. PubMed ID: 16236504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of beta-homophenylalanine based pyrrolidin-2-ylmethyl amides and sulfonamides as highly potent and selective inhibitors of dipeptidyl peptidase IV.
    Nordhoff S; Cerezo-Gálvez S; Deppe H; Hill O; López-Canet M; Rummey C; Thiemann M; Matassa VG; Edwards PJ; Feurer A
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4201-3. PubMed ID: 19515557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based virtual screening approach to identify novel classes of Cdc25B phosphatase inhibitors.
    Park H; Li M; Choi J; Cho H; Ham SW
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4372-5. PubMed ID: 19500977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-C-glycosiduronic acids and beta-C-glycosyl compounds: new PTP1B inhibitors.
    Lin L; Shen Q; Chen GR; Xie J
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6348-51. PubMed ID: 18993066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.